| Application no. and date | 06771162.2 (espacenet) (Federated) (European Patent Register), 20060525 | | Patent/reg. no. and date | DK/EP 1928882, 20130904 | | Publication date | 20080611 | | Priority no. and date | US 684570 P, 20050525 | | EP pub. no. and date |
EP 1928882 20080611 | | Effective date | | | Applicant/owner | PROGENICS PHARMACEUTICALS, INC., 331 Treble Cove Road
North Billerica, MA 01862, US | | Applicant ref. no. | 01786-EP-DK | | Inventor | BOYD, Thomas, A., 279 River Road
Grandview, NY 10960, US,
VERBICKY, Christopher, 992 Ridge River Road
Broadalbin, NY 12025, US,
WAGONER, Howard, 334 Cascade Road
Warwick, NY 10990, US,
SANGHVI, Suketu, P., 1 Hancock Drive
Kendall Park, NJ 18824, US,
ANDRUSKI, Stephen, 7 Sylvan Lane
Clifton Park, NY 12065, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/485 (2006.01) , A61P 1/12 (2006.01) , A61P 25/04 (2006.01) , C07D 489/08 (2006.01) | | Title | (S)-N-METHYLNALTREXON | | Int. application no. | US2006020232 | | Int. publication no. | WO2006127898 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
